The Korean Journal of Medicine

  • 제81권6호
  • /
  • Pages.716-719
  • /
  • 2011
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지

심부전의 약물 치료

Pharmacological Treatment of Heart Failure

  • 유병수 (연세대학교 원주의과대학 심장내과)
  • Yoo, Byung-Su (Division of Cardiology, Yonsei University Wonju College of Medicine)
  • 발행 : 2011.12.01
⟨ 이전 논문 다음 논문 ⟩

초록

Optimal treatment of heart failure is important to reduce hospitalization and mortality. In according to recommendation for treatment from major guideline, most patients with HF should be routinely managed with a combination of 3 types of drugs: a diuretic, an ACEI or an ARB, and a beta blocker. The value of these drugs has been established by the results of numerous large-scale clinical trials, and the evidence supporting a central role for their use is compelling. This review is focused on the drug treatment based on the evidence and practical implication.

키워드

참고문헌

  1. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971;285:1441-1446. https://doi.org/10.1056/NEJM197112232852601
  2. Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010;16:e1-e194. https://doi.org/10.1016/j.cardfail.2010.04.004
  3. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391-e479. https://doi.org/10.1161/CIRCULATIONAHA.109.192065
  4. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416. https://doi.org/10.1093/eurheartj/ehi044
  5. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-259. https://doi.org/10.1056/NEJMoa052256